US Biotech's ``Top Insider'' Keynotes at ANZA Tech Net Showcase; First Ever Event Gives Biotech Companies Access to US Market Opportunities, Expansion and Industry Contacts.Health & Biotechnology Editors ANZA Technology Showcase SAN FRANCISCO--(BUSINESS WIRE)--April 6, 2002 ANZA Technology Network (ANZA Tech Net), the premier networking organization promoting US and Australian/New Zealand technology business collaboration, today announced Dr Cynthia Robbins-Roth as a keynote speaker at the first ever ANZA Technology Showcase to be held in the U.S. (San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden , June 2-4, 2002). Named by Forbes magazine as one of the biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. industry's "top insiders," Dr Roth will share with delegates the business of biotech in the US -- covering the key issues of funding, partnerships, IP and the history and future of the industry. Dr Roth, former Genentech research scientist, is the founder of BioVenture Consultants which provides strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. and technical business assessment to the biotech and VC industry. Her biotech columns appear regularly in national US publications such as Forbes. Dr Roth said she was looking forward to seeing some of the best biotech out of Australia and New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. and is pleased to be involved in the exchange of information between the US and these innovative countries. "Australia and New Zealand are set to really take advantage of this relatively young and fast moving sector -- you have great research facilities and a highly educated population and a strong background in innovation and discovery in the sector," she said. "The challenge will be to move into overseas markets and the ANZA Tech Net Showcase provides the ideal forum for companies looking to expansion, partnerships and collaboration." She said Biotech's Golden Age lies ahead. "As we begin the 21st Century, literally hundreds of new biotech projects begun in the last decade are poised to power into the market place," Dr Roth said. "This explosion will fuel opportunities for investors and employees alike and we will all benefit from the products." "Every day the industry labs generate more information about how our bodies work, in sickness and in health, down to the single molecule level. "For the first time in history, it is possible to design treatments for diseases such as Alzheimer's disease Alzheimer's disease (ăls`hī'mərz, ôls–), degenerative disease of nerve cells in the cerebral cortex that leads to atrophy of the brain and senile dementia. , Lou Gehrigs's disease, breast and prostate cancer prostate cancer, cancer originating in the prostate gland. Prostate cancer is the leading malignancy in men in the United States and is second only to lung cancer as a cause of cancer death in men. and heart disease -- and aim those drugs directly at molecular causes of the disease. More effective drugs with fewer nasty side effects Side effects Effects of a proposed project on other parts of the firm. will be possible because of biotechnology," she said. ANZA Tech Net Chairman Guy Manson said the organization was particularly honored to have Dr Roth as keynote. "Not only will Dr Roth be able to provide a close-up on the US biotech industry, she is also an invaluable facilitator for executives wanting to develop contacts in the industry," he said. He said there would also be an opportunity for delegates to receive a signed copy of Dr Roth's biotech industry best seller "The business of Biotech -- from Alchemy alchemy (ăl`kəmē), ancient art of obscure origin that sought to transform base metals (e.g., lead) into silver and gold; forerunner of the science of chemistry. to IPO (Initial Public Offering) The first time a company offers shares of stock to the public. While not a computer term per se, many founders, employees and insiders of computer companies have found this acronym more exciting than any tech term they ever heard. " -- the number one recommendation on the Bay Area Bio Science Center site. Leading New Zealand companies This is a list of major companies based in New Zealand. For convenience, the word "Limited", which every company registered or reregistered under the Companies Act 1993 (with one historic exception) must have at the end of its name, is reduced to the common and universally are expected to participate in the Showcase, presenting their business propositions to executives from some of North America's largest and most innovative tech, biotech and business services organizations. The Showcase will also feature business forums -- addressing key issues that affect companies looking to establish a presence or conduct business development in the US. About the Showcase June 2-4, 2002, Hotel Nikko, San Francisco. Presentation and marketing packages available -- Early Bird Registration cut off on April 19, 2002 www.anzatechnet.com/conference/ About Trade New Zealand Trade New Zealand is the Government's trade and investment promotion agency, mandated to help increase New Zealand's foreign exchange earnings and encourage inward direct investment and business location. For further information exporters should visit www.tradenz.govt.nz. About ANZA Tech Net ANZA Technology Network is a non-profit organization A non-profit organization (abbreviated "NPO", also "non-profit" or "not-for-profit") is a legally constituted organization whose primary objective is to support or to actively engage in activities of public or private interest without any commercial or monetary profit purposes. backed by Investment New Zealand, Macquarie, Silicon Valley Bank, Intel and Australia's The National Office for the Information Economy (NOIE v. t. 1. To annoy. See Noy. ). Its aim is to establish a powerful network of companies and executives who operate in the Australian-New Zealand-US technology sectors, and provide members tangible benefits in the areas of information exchange, networking, idea sharing and business development. Note to editors: please email Susan Fitzpatrick for enquiries about media attendance at the Showcase and/or if you would like be registered for the Showcase Media Information Bulletins re: updates on speakers, sponsors, interviews with delegate companies, Leadership Award recipient etc. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion